Over 80% of 5-Year-Olds Eligible for Supplemental Dose of Pneumococcal Vaccine: Pfizer Survey

February 2, 2017
Over 80% of five-year-old children who had been inoculated with the 7-valent pediatric pneumococcal vaccine would be eligible for a supplemental dose, a survey revealed. Pfizer Japan announced on February 1 the results of a survey it conducted to determine...read more